Williams Jason A, Loeys Bart L, Nwakanma Lois U, Dietz Harry C, Spevak Philip J, Patel Nishant D, François Katrien, DeBacker Julie, Gott Vincent L, Vricella Luca A, Cameron Duke E
Division of Cardiac Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
Ann Thorac Surg. 2007 Feb;83(2):S757-63; discussion S785-90. doi: 10.1016/j.athoracsur.2006.10.091.
Loeys-Dietz syndrome (LDS) is a recently described genetic aortic aneurysm syndrome resulting from mutations in receptors for the cytokine transforming growth factor-beta. Phenotypic features include a bifid uvula, hypertelorism, cleft palate, and generalized arterial tortuosity, but risk of thoracic aortic rupture and dissection is the principle focus of management and exceeds that of most known connective tissue disorders. Our surgical experience with LDS was reviewed to assess outcomes and develop guidelines for management of this aggressive disease.
We retrospectively reviewed medical records of all LDS patients from two institutions and obtained follow-up data from medical records and patient contacts.
Clinical criteria and genotyping were used to identify 71 patients. Before surgical intervention, 6 patients (9%) died from aneurysm rupture or dissection, which occurred in several patients with aortic diameters of less than 4.5 cm and as early as 6 months of age. Thoracic aortic aneurysm surgery was performed in 14 children and 7 adults. Operations included valve-sparing root replacement (VSRR) in 13, Bentall procedure in 5, arch replacement in 2, and VSRR with arch replacement in 1. There were no deaths at the primary operation, although 3 patients died 2, 5, and 11 years after surgery from rupture of the descending thoracic (n = 2) or abdominal aorta (n = 1).
LDS is an aggressive aortic aneurysm disease with a propensity toward rupture and dissection at a younger age and smaller aortic diameters than in other connective tissue disorders, particularly in the ascending aorta. Early recognition of the phenotype, prophylactic intervention, and meticulous surveillance of the distal aorta and vascular tree are warranted for optimal management.
洛伊迪茨综合征(LDS)是一种最近被描述的遗传性主动脉瘤综合征,由细胞因子转化生长因子-β受体的突变引起。其表型特征包括悬雍垂裂、眼距过宽、腭裂和全身性动脉迂曲,但胸主动脉破裂和夹层的风险是治疗的主要关注点,且超过了大多数已知的结缔组织疾病。我们回顾了LDS的手术经验,以评估治疗结果并制定针对这种侵袭性疾病的管理指南。
我们回顾性分析了来自两个机构的所有LDS患者的病历,并从病历和患者联系中获取随访数据。
通过临床标准和基因分型确定了71例患者。在手术干预前,6例患者(9%)死于动脉瘤破裂或夹层,其中几例患者的主动脉直径小于4.5 cm,最早发生在6个月大时。14名儿童和7名成人接受了胸主动脉瘤手术。手术包括13例保留瓣膜的根部置换术(VSRR)、5例Bentall手术、2例主动脉弓置换术和1例VSRR联合主动脉弓置换术。初次手术时无死亡病例,尽管有3例患者在术后2年、5年和11年死于降主动脉(n = 2)或腹主动脉(n = 1)破裂。
LDS是一种侵袭性主动脉瘤疾病,与其他结缔组织疾病相比,更倾向于在较年轻的年龄和较小的主动脉直径时发生破裂和夹层,尤其是升主动脉。为了实现最佳管理,早期识别表型、进行预防性干预以及对远端主动脉和血管树进行细致监测是必要的。